Biomerica, Inc. provided earnings guidance for the second quarter ended November 30, 2021. For the period the company expects to report revenue of approximately $4.6 million, an increase of 238% as compared to the second quarter of fiscal 2021 revenues of approximately $1.4 million. The increased revenue was driven primarily by increased demand for the Company’s Covid tests. The company also expects to report an operating loss of between $0.9 million and $1.3 million.